Liver Tumor Model with Implanted Rhabdomyosarcoma in Rats: MR Imaging, Microangiography, and Histopathologic Analysis
Authors:
- Xihe SunXSXihe Sun
- Frederik De KeyzerFKFrederik De Keyzer
- Jie YuJYJie Yu
- Ronald PeetersRPRonald Peeters
- Walter CoudyzerWCWalter Coudyzer
- Vincent VandecaveyeVVVincent Vandecaveye
- Willy LanduytWLWilly Landuyt
- Hilde BosmansHBHilde Bosmans
- Paul Van HeckePHPaul Van Hecke
- Guy MarchalGMGuy Marchal
- Yicheng NiYNYicheng Ni
- 1 May 2006
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 239 (2) , 554-562
Abstract
In compliance with institutional regulations for care and use of laboratory animals, the aim of this study was to establish and characterize a rodent liver tumor model to provide a platform for preclinical assessment of new diagnostic and therapeutic strategies. A rhabdomyosarcoma tumor was implanted in the right and left liver lobes of 20 rats, for a total of 40 tumors. T1- and T2-weighted magnetic resonance (MR) images, diffusion-weighted images, and dynamic susceptibility contrast agent-enhanced perfusion-weighted images were obtained up to 16 days after tumor implantation and were compared with postmortem three-dimensional computed tomographic (CT) images, digital microangiograms, and histopathologic findings. Fifteen tumors were examined with proton ((1)H) MR spectroscopy. All tumors grew, with a mean volume doubling time of 2.2 days +/- 0.9 (standard deviation) and a final size of 591 mm(3)+/- 124. The rhabdomyosarcoma tumor showed hypervascularity at MR imaging, three-dimensional CT, microangiography, and histologic analysis. On dynamic susceptibility contrast-enhanced perfusion-weighted images, the maximum signal intensity decrease differed in time and extent between the tumor and the liver, with a significantly (P < .001) higher relative blood volume, relative blood flow, and permeability value in the tumor than in the liver. With (1)H MR spectroscopy, the rhabdomyosarcoma tumor and the liver featured significant (P < .001) choline and lipid peaks, respectively. Implantation of a rhabdomyosarcoma tumor in the livers of rats is feasible and reproducible, and this animal model seems promising for future testing of new diagnostic and therapeutic strategies.Keywords
This publication has 29 references indexed in Scilit:
- Relationship between the imaging features and pathologic alteration in hepatoma of ratsWorld Journal of Gastroenterology, 2003
- An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging featuresWorld Journal of Gastroenterology, 2002
- In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Quantitative study of the growth of experimental hepatic tumors in rats by using magnetic resonance imagingInternational Journal of Cancer, 1992
- Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging.Radiology, 1991
- Hepatic metastases: Rat models for imaging researchMagnetic Resonance Imaging, 1989
- In vivo emergence of a highly metastatic tumour cell line from a rat rhabdomyosarcoma after treatment with an alkylating agentBritish Journal of Cancer, 1988
- Magnetic Resonance, Pathology and Physiology of the BA1112 Rhabdomyosarcoma In VivoInvestigative Radiology, 1988
- Dynamic spin-echo MRI of liver cancer using Gadolinium-DTPA: animal investigationAmerican Journal of Roentgenology, 1986
- Cellular proliferation patterns in an experimental Rhabdomyosarcoma in the ratEuropean Journal of Cancer (1965), 1967